Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer
about
Radiolabeling of DOTA-like conjugated peptides with generator-produced (68)Ga and using NaCl-based cationic elution method.Single fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer.Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.Prostate-specific membrane antigen positron emission tomography in prostate cancer: a step toward personalized medicine.Cancer stratification by molecular imaging.Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapyIntegration of (68)Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study.Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology.44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617-preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617.Impact of PET acquisition durations on image quality and lesion detectability in whole-body 68Ga-PSMA PET-MRI.Synthesis and pre-clinical evaluation of a new class of high-affinity 18F-labeled PSMA ligands for detection of prostate cancer by PET imaging.Evolving role of positron emission tomography (PET) in urological malignancy.PET-based molecular imaging in personalized oncology: potential of the assessment of therapeutic outcome.Next revolution in molecular theranostics: personalized medicine for urologic cancers.Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted (18)F-DCFPyL in peripheral ganglia.Comparison of hybrid (68)Ga-PSMA-PET/CT and (99m)Tc-DPD-SPECT/CT for the detection of bone metastases in prostate cancer patients: Additional value of morphologic information from low dose CT.68Ga-THP-PSMA: A PET Imaging Agent for Prostate Cancer Offering Rapid, Room-Temperature, 1-Step Kit-Based Radiolabeling.(68)Ga-PSMA-11 PET/CT: the rising star of nuclear medicine in prostate cancer imaging?The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity.68Ga-prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Prostate Cancer Imaging: A Narrative Literature Review.The reconstruction algorithm used for [68Ga]PSMA-HBED-CC PET/CT reconstruction significantly influences the number of detected lymph node metastases and coeliac ganglia.Design of Internalizing PSMA-specific Glu-ureido-based Radiotherapeuticals.Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma.Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.Semiquantitative Parameters in PSMA-Targeted PET Imaging with 18F-DCFPyL: Variability in Normal-Organ Uptake.Radiochemistry and Preclinical PET Imaging of 68Ga-Desferrioxamine Radiotracers Targeting Prostate-Specific Membrane Antigen.Pharmaceuticals—Special Issue on Radiopharmaceutical Chemistry between Imaging and Endoradiotherapy.Simple, mild, one-step labelling of proteins with gallium-68 using a tris(hydroxypyridinone) bifunctional chelator: a 68Ga-THP-scFv targeting the prostate-specific membrane antigen.Integration of CT urography improves diagnostic confidence of 68Ga-PSMA-11 PET/CT in prostate cancer patients.Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling† †Electronic supplementary information (ESI) available. CCDC 1564603. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c7ra09076e.Procedures for the GMP-Compliant Production and Quality Control of [18F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer.Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling.Synthesis and evaluation of 68 Ga-HBED-CC-EDBE-folate for positron-emission tomography imaging of overexpressed folate receptors on CT26 tumor cells.[68Ga]PSMA-HBED-CC Uptake in Osteolytic, Osteoblastic, and Bone Marrow Metastases of Prostate Cancer Patients.Early dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions.68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour.Comparative evaluation of 68 Ga-labeled NODAGA, DOTAGA, and HBED-CC-conjugated cNGR peptide chelates as tumor-targeted molecular imaging probes.Unusual Uptake of Prostate Specific Tracer 68Ga-PSMA-HBED-CC in a Benign Thyroid Nodule.Convenient Preparation of [(68)Ga]DKFZ-PSMA-11 Using a Robust Single-Vial Kit and Demonstration of Its Clinical Efficacy.
P2860
Q30314932-D3F34A0D-7D91-41C7-8397-08134B81EC41Q30376901-C9A961DE-1464-4735-A963-081B0D663B89Q33841484-CBACFD46-F917-4D0C-B5C0-6C89A0205C98Q33914844-09E401EB-E0E5-466E-8F2C-2A009046E00CQ35380664-12D03247-4AD2-437C-B232-7E2A6B481FA2Q36289592-483B4C2E-E4F8-4A05-A532-0A905F58028EQ36942136-8618A4BA-78A8-4402-848E-A8735AF58AF0Q37541876-D77B4886-C991-483B-B219-B8FDD1EC56B3Q37594922-F1F10839-F7E8-4AC2-939C-D62E356187B2Q37626953-A742E855-47BB-48A9-819C-28C0935123B1Q37662752-1EE77F7F-F3C0-446F-9C54-579BE7F80A58Q38269763-599E5C57-E3C6-4046-B2D3-B1A6A031C899Q38389152-8D8CBB2A-F5F8-4A9E-BEE8-4E177D5D87A2Q38559336-B54C93DA-2183-481B-B470-B7CF174AAC17Q38638455-3D6A04E1-6CA5-4981-96FE-D891ED8AB9ECQ38639486-693A58CE-017A-4F34-BEA6-E113F685735EQ38707752-63CAF012-F2CD-45D5-9481-5F81A6234385Q38747415-92C454A5-942A-414D-8DCE-694BEB32F3DFQ38876206-AB83448D-9248-48E1-8DD0-F75A543CD325Q38952552-7597D04A-79D7-459A-BC39-CF5F360B8229Q39143896-D2C73981-E541-46A2-8920-C9F757818F41Q39697612-34F58A51-BD1A-49A7-96EB-A69664EA626AQ40327142-028C02CD-FFB3-4577-B688-46CA8D4AA508Q41319390-454C1DFA-F7EC-4C01-BA46-BD2CD775C6F2Q42257970-5CFA96D3-6583-4137-A302-20FEC50A41DCQ45105171-BDF549B0-2EDB-4ADF-A41D-04BA90681120Q45753373-EA35401B-4BFC-4E55-BBF5-9E8ADB525E20Q45925924-511F517B-5EC3-4AF5-BFB8-2B78E3D18E96Q47105948-8D339924-2230-4177-BFB8-A02B09D65D04Q47109640-C19C6C50-0C5C-49F1-8C4A-4F9D4B51A73EQ47115169-7C268213-B6D5-417D-9EA2-BC2A912BE31FQ47156816-7B86636F-357C-468D-A47A-F0FC6C40CB7CQ47195725-41012774-1B6F-4B72-B64D-5CB58849BC23Q48054086-4E6F60BD-6B65-4F71-AFBF-5BD2DD980F2DQ48127957-B79C3828-2033-447B-B1D0-6AC3D6CF0924Q48189196-980AEB78-1983-49E8-8F38-C4287C65EC88Q48295687-56F2438F-C83C-45F8-B22F-3AED48B7D067Q48317907-732EE7C8-A0CE-475D-A840-0DE511245EA0Q50285831-EBCA45AA-63CD-4DEB-9F33-77E3A277F988Q51440427-3B95D732-B13F-409E-A5E4-F758E8BA78EB
P2860
Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Novel Preclinical and Radiopha ...... for Imaging of Prostate Cancer
@en
type
label
Novel Preclinical and Radiopha ...... for Imaging of Prostate Cancer
@en
prefLabel
Novel Preclinical and Radiopha ...... for Imaging of Prostate Cancer
@en
P2093
P2860
P50
P356
P1433
P1476
Novel Preclinical and Radiopha ...... for Imaging of Prostate Cancer
@en
P2093
Martin Schäfer
Michael Eisenhut
Miriam Müller
Ulrike Bauder-Wüst
Ute Hennrich
Uwe Haberkorn
Yvonne Remde
P2860
P304
P356
10.3390/PH7070779
P577
2014-06-30T00:00:00Z